PLEASANTON, Calif., July 24 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, today announced that it will report its operating results for the second quarter and first half of fiscal 2006 on Monday, July 31.
The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 8:30 a.m., Pacific Daylight Time (11:30 a.m., Eastern Daylight Time), Monday, July 31, hosted by Gary F. Burbach, president and chief executive officer, and Cynthia Lucchese, senior vice president and chief financial officer.
The teleconference can be accessed by calling 913-981-5509, passcode 8489625. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available via the Internet at http://phx.corporate- ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1343061 or at http://www.thoratec.com .
A replay of the conference call will be available through Monday, August 7, via http://www.thoratec.com , or by telephone at 719-457-0820, passcode 8489625.
Thoratec Corporation is a world leader in therapies to address advanced stage heart failure. The company’s product line includes the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 10,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s web sites at http://www.thoratec.com or http://www.itcmed.com .
Thoratec Corporation
CONTACT: Cynthia Lucchese, Senior Vice President, Chief Financial Officerof Thoratec Corporation, +1-925-847-8600; or Neal Rosen of Kalt Rosen &Company, +1-415-397-2686, for Thoratec Corporation
Web site: http://www.thoratec.com/
